KMS Medisurgi (BOM:540468) ROCE %: 1.81% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540468 KMS Medisurgi Ltd BOM:540468
79 GF Score
Price ₹132.80
GF Value ₹111.50
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is KMS Medisurgi ROCE %?

KMS Medisurgi BOM:540468 79 ROCE % is 1.81% as of Mar. 2026. GuruFocus rates BOM:540468 with a GF Score™ of 79/100 and a GF Value™ of ₹111.50 (Modestly Overvalued). The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. KMS Medisurgi's annualized ROCE % for the quarter that ended in Mar. 2026 was 1.81%.

KMS Medisurgi  (BOM:540468) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

KMS Medisurgi ROCE % Related Terms

KMS Medisurgi ROCE % Historical Data

* Premium members only.

The historical data trend for KMS Medisurgi's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KMS Medisurgi ROCE % Chart

KMS Medisurgi Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.79 8.30 7.61 8.06 4.83

KMS Medisurgi Semi-Annual Data
Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.49 2.63 13.26 7.78 1.81
BOM:540468
79GF Score
KMS Medisurgi Ltd BOM:540468
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KMS Medisurgi ROCE % Calculation

KMS Medisurgi's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=4.368/( ( (103.421 - 13.436) + (105.48 - 14.598) )/ 2 )
=4.368/( (89.985+90.882)/ 2 )
=4.368/90.4335
=4.83 %

KMS Medisurgi's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=1.658/( ( (121.635 - 29.734) + (105.48 - 14.598) )/ 2 )
=1.658/( ( 91.901 + 90.882 )/ 2 )
=1.658/91.3915
=1.81 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.81% mean?
KMS Medisurgi (BOM:540468) has a ROCE % of 1.81% as of Mar. 2026.
Is KMS Medisurgi's ROCE % too high?
KMS Medisurgi's current ROCE % is 1.81%. The Medical Devices & Instruments industry median ROCE % is 2.26. KMS Medisurgi's value of 1.81% is 19.9% below this industry median. Overall, KMS Medisurgi has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's ROCE % compare to ISRG and BDX?
KMS Medisurgi's ROCE % of 1.81% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.26. KMS Medisurgi's value of 1.81% is 19.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.26, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMS Medisurgi's current ROCE % of 1.81% is 19.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current ROCE % is 1.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
Based on GuruFocus' analysis, KMS Medisurgi (BOM:540468) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹111.50, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current ROCE % is 1.81% and 19.9% below the Medical Devices & Instruments industry median of 2.26. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current ROCE % is 1.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KMS Medisurgi (BOM:540468) Overvalued in 2026?

Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued. The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.50. GuruFocus considers KMS Medisurgi to be Modestly Overvalued.

Key valuation signals for BOM:540468:

  • ROCE %: 1.81%
  • GF Value™: ₹111.50 vs. price of ₹132.80 (19.1% above fair value)
  • GF Score™: 79/100 with 8 warning signs
  • Industry Position: 19.9% below the Medical Devices & Instruments median

No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KMS Medisurgi Business Description

Address Princess Street, Ground Floor, 297-301, May Building, Marine Lines (East, Mumbai, MH, IND, 400002
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score

Get the complete analysis for BOM:540468

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹132.80
Price
₹111.50
GF Value